Navigation Links
Micromet Expands Committed Equity Financing Facility to $75 Million
Date:12/2/2008

securities, nor shall there be any sale of these securities in any state which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state.

About Micromet, Inc.

Micromet, Inc. (www.micromet-inc.com) is a biopharmaceutical company with offices in Bethesda, Maryland and Munich, Germany. The Company is developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. The Company uses its proprietary BiTE(R) antibody platform to create a new class of antibodies that specifically activate T cells from the patient's own immune system to eliminate cancer cells or other disease-related cells. Four of the Company's antibodies are currently in clinical trials, with the remainder of its product pipeline in preclinical development. The Company's lead program is a BiTE antibody known as blinatumomab, or MT103. It is in a phase 2 clinical trial for the treatment of patients with acute lymphoblastic leukemia and a phase 1 clinical trial for the treatment of patients with non-Hodgkin's lymphoma. Micromet is developing blinatumomab in collaboration with MedImmune, a subsidiary of AstraZeneca plc. Micromet's second BiTE antibody in clinical development is MT110, which targets the epithelial cell adhesion molecule (EpCAM). The Company owns all rights to MT 110, which is currently in a phase 1 clinical trial for the treatment of patients with solid tumors. The Company's third clinical stage antibody is adecatumumab, also known as MT201, a conventional human monoclonal antibody that targets EpCAM-expressing solid tumors. Micromet is developing adecatumumab in collaboration with Merck Serono in a phase 1b clinical trial evaluating adecatumumab in combination with docetaxel for the treatment of patients with metastatic breast cancer. Micromet has licensed a fourth c
'/>"/>

SOURCE Micromet, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Micromet Announces Changes in Management Team
2. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
3. Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research
4. Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies
5. Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma
6. Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study
7. Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors
8. Micromet to Present Clinical Update for BiTE Antibody MT103/MEDI-538 at the International Conference on Malignant Lymphomas
9. Micromets BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkins Lymphoma
10. Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
11. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... N.Y. , May 17, 2013  Lakeland Industries, ... manufacturer of protective clothing for industry, healthcare and to ... will release its financial results for the fiscal 2013 ... Tuesday, May 21, 2013 at stock market close and ... at 4:30 p.m. eastern. (Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ...
(Date:5/17/2013)... May 17, 2013  Sony Biotechnology Inc. ("Sony") today announced ... holder and 130um sorting chip.  Sony will also be exhibiting ... new SH800 Cell Sorter, the EC800 flow cytometer, and new ... CYTO 2013, which will be held at the ... Diego, California , from May 20 - 22.  ...
(Date:5/17/2013)... , May 17, 2013  ConvaTec today announced that it will ... Ken Berger , CEO, and Ed Borkowski ... ET live via telephone. To participate in the conference ... 366-0267. To participate in the conference call outside the U.S. ... The conference ID is 72195398. Participants should dial in 10 ...
Breaking Medicine Technology:Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2Sony Delivers New Technology for Science to CYTO 2013 2
... (Nasdaq: CADX ) today announced that it has ... common stock at a price to the public of $3.75 ... shares, after deducting the underwriting discounts and commissions and estimated ... has granted the underwriters for the offering a 30-day option ...
... 15, 2011 Reportlinker.com announces that a ... its catalogue: The Outlook ... http://www.reportlinker.com/p0617406/The-Outlook-for-Pharmaceuticals-in-North-East-Asia ... pharmaceutical markets that present immense potential for ...
Cached Medicine Technology:Cadence Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2Cadence Pharmaceuticals Announces Pricing of Public Offering of Common Stock 3The Outlook for Pharmaceuticals in North East Asia 2The Outlook for Pharmaceuticals in North East Asia 3The Outlook for Pharmaceuticals in North East Asia 4
(Date:5/18/2013)... May 18, 2013 Family Magazine of Washington ... excellence by Follow Media Consulting, Inc. in the category of ... continued commitment and dedication of the areas best in the ... one knows parenting better than Brenda Hyde, a mother of ... help parents know about the vast resources available to them ...
(Date:5/18/2013)... 18, 2013 Although obesity is associated ... association between obesity and esophageal adenocarcinoma, a type of ... tumors. As reported on Cancer.gov, last reviewed ... twice as likely as those of normal and healthy ... between obesity and esophageal cancer is not well understood, ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 6Webs.com is ... simple to read reviews and comprehensive comparisons make 6Webs.com ... home security reviews. 6Webs.com just recently finished conducting their ... providers. , Tim Smythe from 6Webs.com reports, "There has ... due to their ease of use, expandability and mobility. ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 The Ayurvedic ... ayurvedic education institution in the West. Program is available ... , Ayurveda is a healing modality practiced for over ... it is considered that health begins when an individual ... understanding of their individual needs. Ayurveda aims to heal ...
(Date:5/18/2013)... 18, 2013 The American Society ... A. Kitzhaber, M.D., (D) to sign a bill (HB ... minors under the age of 18 from tanning indoors. ... third state in the nation to enact an under-18 ... indoor tanning bans for minors. Nationwide, 34 states and ...
Breaking Medicine News(10 mins):Health News:Summer Camps in DC "Best of the Best" Awarded to Family Magazine of Washington DC for Excellence by Follow Media Consulting, Inc. 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3Health News:Best Wireless Home Security System Companies Released by 6Webs.com 2Health News:Ayurveda Training in Mexico Offered by Escuela de Ayurveda de California, a Leading Institution in the West 2Health News:ASDSA Urges Oregon Governor to Sign Under-18 Indoor Tanning Restrictions 2
... , ... offers spiritual upliftment to people of all faiths in Dallas, TX, on June 27th and ... two days to experience her love and compassion in person. , ... Dallas, TX (PRWEB) June 18, 2010 -- The ‘Hugging ...
... ... used as a barometer for hiring this fall, we are about to see a significant pickup ... (PRWEB) June ... to be a leading indicator for future hiring activity. “It only makes sense, says RD Whitney, ...
... new model for testing Alzheimer,s treatments has reassured researchers that ... if treatment is interrupted. Scientists at Washington University School ... studied the effects of a class of drugs known as ... cause a build-up of proteins linked to Alzheimer,s disease and ...
... Society lauds latest restrictions , THURSDAY, June 17 (HealthDay ... the Tobacco Control Act approaches, several key provisions of the ... power to regulate tobacco products are set to take effect. ... on terms such as "light," "low" and "mild" in all ...
... particular concern to thyroid experts , THURSDAY, June 17 ... thyroid experts worry that some may obtain too little ... dietary iodine in the U.S. and worldwide. Iodine, essential ... through diet," several members of the American Thyroid Association ...
... Thanks to ... will be in front of him instead of behind him. His father’s dream is now a reality ... ... to Mercy Ships, Abel Dalome, disfigured for 11 years, will walk home a different way. His ...
Cached Medicine News:Health News:The ‘Hugging Saint' Amma Visits Dallas June 27-28, 2010, Offering Spiritual Upliftment to People of All Faiths 2Health News:Onrec Predicts Significant Recruiting Activity this Fall 2Health News:Onrec Predicts Significant Recruiting Activity this Fall 3Health News:Onrec Predicts Significant Recruiting Activity this Fall 4Health News:New model suggests feared side effect of Alzheimer's drugs is unlikely 2Health News:New Tobacco Regulations to Take Effect 2Health News:New Tobacco Regulations to Take Effect 3Health News:Iodine Levels a Worry as Salt Use Declines 2Health News:Mercy Ships Releases Abel Dalome Just in Time for Father's Day - A Father's Dream Becomes a Reality, 2Health News:Mercy Ships Releases Abel Dalome Just in Time for Father's Day - A Father's Dream Becomes a Reality, 3
... to connect an infusion ... pump, and then to ... order to conduct urodynamics ... Laborie Medical Technologies infusion ...
Used for cystometry and urethral pressure profilometry. A loop is employed to enhance catheter retention and stabilization within the bladder. Supplied sterile in peel-open packages. Intended for one...
... Used for cystometry and urethral pressure ... for faster filling of the bladder ... Dual lumen catheter construction allows the ... is performed. Triple lumen catheter construction ...
... The Triage® Cardiac Panel is ... the rapid quantitative determination of ... in ethylenediaminetetraacetic acid (EDTA) whole ... test is used as an ...
Medicine Products: